Evidence map›Paper›PMID 30582197›Full record

ArticleClinical cardiology2019

A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography.

Nasrien E Ibrahim, Cian P McCarthy, Shreya Shrestha, Hanna K Gaggin, Renata Mukai, Craig A Magaret, Rhonda F Rhyne, James L Januzzi

Abstract read
In one paragraph

Article in Clinical cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Observational
  13. Artificial Intelligence in Coronary Artery Interventions: Preprocedural Planning and Procedural Assistance.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Role of C-Reactive Protein in Kidney Diseases.Kidney diseases (Basel, Switzerland) · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nasrien E IbrahimCardiology Division, Massachusetts General Hospital, Boston, Massachusetts.
Cian P McCarthyCardiology Division, Massachusetts General Hospital, Boston, Massachusetts.
Shreya ShresthaCardiology Division, Massachusetts General Hospital, Boston, Massachusetts.
Hanna K GagginCardiology Division, Massachusetts General Hospital, Boston, Massachusetts.
Renata MukaiCardiology Division, Massachusetts General Hospital, Boston, Massachusetts.
Craig A MagaretPrevencio, Inc., Kirkland, Washington.
Rhonda F RhynePrevencio, Inc., Kirkland, Washington.
James L JanuzziCardiology Division, Massachusetts General Hospital, Boston, Massachusetts.ORCID https://orcid.org/0000-0002-8338-1798

Funding

Prevencio, Inc
6 · The paper itself

Abstract

backgroundStandard measures of kidney function are only modestly useful for accurate prediction of risk for acute kidney injury (AKI). HYPOTHESIS: Clinical and biomarker data can predict AKI more accurately.

methodsUsing Luminex xMAP technology, we measured 109 biomarkers in blood from 889 patients prior to undergoing coronary angiography. Procedural AKI was defined as an absolute increase in serum creatinine of ≥0.3 mg/dL, a percentage increase in serum creatinine of ≥50%, or a reduction in urine output (documented oliguria of <0.5 mL/kg per hour for >6 hours) within 7 days after contrast exposure. Clinical and biomarker predictors of AKI were identified using machine learning and a final prognostic model was developed with least absolute shrinkage and selection operator (LASSO).

resultsForty-three (4.8%) patients developed procedural AKI. Six predictors were present in the final model: four (history of diabetes, blood urea nitrogen to creatinine ratio, C-reactive protein, and osteopontin) had a positive association with AKI risk, while two (CD5 antigen-like and Factor VII) had a negative association with AKI risk. The final model had a cross-validated area under the receiver operating characteristic curve (AUC) of 0.79 for predicting procedural AKI, and an in-sample AUC of 0.82 (P < 0.001). The optimal score cutoff had 77% sensitivity, 75% specificity, and a negative predictive value of 98% for procedural AKI. An elevated score was predictive of procedural AKI in all subjects (odds ratio = 9.87; P < 0.001).

conclusionsWe describe a clinical and proteomics-supported biomarker model with high accuracy for predicting procedural AKI in patients undergoing coronary angiography.

Indexed as

Artificial IntelligenceAcute Kidney InjuryAgedBiomarkersContrast MediaCoronary AngiographyCoronary Artery DiseaseCreatinineFemaleHumansIncidenceMalePredictive Value of TestsProspective StudiesProteomicsRisk AssessmentBiomarkersContrast MediaCreatininecoronary angiographykidney injuryrisk predictionrisk score

Identifiers

PMID30582197
PMCPMC6712314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.